KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts.

BJC Rep · 2025 · PMC12540680 · PMID 41120702

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The KRAS -G12S subgroup showed a trend for being treated with metastasectomies and/or LATs less often.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.